UnitedHealth stock fills in the gap as market assesses the bottom is in

UNH stock rises more than 7%, closing the gap from May 15.
New CEO Stephen Hemsley buys $25 million worth of UNH stock.
Shareholders are still waiting to hear about the Justice Department's fraud probe of UnitedHealth.
US market largely slumps on Moody's downgrade of US government debt.

Clay Webster FXStreet

UnitedHealth Group (UNH), the largest private health insurer in the United States (US), has seen its share price rise more than 7% on Monday to fill the gap created by the May 15 plunge. Now trading north of $314, the daily chart portrays a sell-off that has likely already reached its bottom and has now begun a long trek higher toward a period of consolidation.

Wall Street analysts have largely lowered their price targets for UNH stock between $350 and $400.

The Dow Jones Industrial Average (DJIA) is largely being held up slightly by UNH gains, while the S&P 500 and the NASDAQ Composite both sink moderately lower as the market deals with the fallout from Moody's downgrading US debt late Friday.

UnitedHealth Group stock news

UNH stock has crated over the past month since mid-April when UnitedHealth cut its earnings guidance for 2025 by about 12% before suspending guidance entirely last week in the face of replacing its CEO.

However, former Chair and newly-installed CEO Stephen Hemsley purchased more than $25 million worth of UNH stock on Friday, according to filings with the Securities and Exchange Commission (SEC). The 86.7K shares that Hemsley bought were purchased at an average price of $288.57 and fortified bullish instincts that Thursday's five-year low at $248.88 was the bottom.

Three directors also purchased a combined $1.6 million worth of shares last Wednesday and Thursday, and CFO John Rex bought another 17.2K shares on Friday. This heavy level of insider buying tells the market that the company's executives don't expect recent news to be insurmountable.

Last week, according to The Wall Street Journal, the US Justice Department opened a fraud probe into UnitedHealth's Medicare Advantage business. The article suggests that the regulators are considering whether the company added unnecessary diagnoses to some patients' medical records.

UnitedHealth Group stock forecast

UnitedHealth Group stock has risen above the May 14 low at $307.11 on Monday. This fills in the gap created by May 15's much lower open.

Now trading north of $314, UNH shares have overcome the 161.8% Fibonacci Extension that briefly held up the deluge during the previous week. The next targets for bulls come at the 161.8% Fibonacci Retracement (not shown) at $334.76, the May 13 high at $342, and then the May 12 low at $376.84. Markets love to fill in gaps, so the retracement to $376.84 will be a major point of interest.

UNH daily stock chart

Premium

You have reached your limit of 3 free articles for this month.

Start your subscription and get access to all our original articles.

Subscribe to Premium Sign In

Author

Clay Webster

FXStreet

Clay Webster grew up in the US outside Buffalo, New York and Lancaster, Pennsylvania. He began investing after college following the 2008 financial crisis.

AUD/USD bounces off nearly two-month low; upside seems limited

AUD/USD rebounds from its lowest level since April 13, touched during the Asian session on Monday, as the US Dollar pauses following Friday's upbeat US NFP-led blowout rally to a two-month high. However, persistent geopolitical uncertainties, along with surging bets on Fed rate hikes, might continue to act as a tailwind for the USD. Furthermore, diminishing odds of a near-term RBA rate hike should cap gains for the Aussie.

USD/JPY bulls seem hesitant amid intervention fears

USD/JPY touches a fresh high since late April following an Asian session dip, though intervention fears limit losses for the Japanese Yen (JPY) and cap the upside. This counters Japan’s revised GDP print, which confirmed that the economy lost momentum in the first quarter. Meanwhile, Friday's upbeat US NFP report lifted bets of a Fed rate hike and favors the US Dollar bulls, backing the case for a further move higher for the currency pair.

Gold recovers slightly from the $4,300 neighborhood; not out of the woods yet

Gold attracts some buyers at the start of a new week and reverses part of Friday's decline to its lowest since March 24, around the $4,300 mark. The US Dollar pauses after Friday’s upbeat US NFP-led blowout rally to a two-month high and supports the bullion. However, a surge in bets on a Fed rate hike, along with geopolitical uncertainties, favors USD bulls. The backs the case for the emergence of fresh sellers around the precious metal at higher levels.

Week ahead: Fed countdown begins amid US inflation data and geopolitical risks

The countdown to the biggest event of the year so far, the first Fed meeting under Chair Warsh on June 17, has officially commenced. Next week’s key events could serve as the best appetizer for Warsh’s first press conference, although market participants will probably be distracted by developments elsewhere.

Week ahead – Fed countdown begins amid US inflation data and geopolitical risks

Fed Chair Warsh’s first meeting approaches as key US inflation data could reshape expectations. Oil prices remain elevated as US-Iran talks continue; tariffs also return to the spotlight. ECB is expected to hike; will it be a one-off move or is July live?

The US economy defies the rules: 100 days into the Oil shock and the recession signal is still missing

More than three months after the start of the Iran war and the resulting disruption to global energy markets, the US economy continues to display remarkable resilience. The conflict has triggered a sharp rise in Oil prices, reignited inflationary pressures and fueled widespread concerns about a potential economic slowdown.